uniQure NV
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About QURE
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Find out what a historical investment in uniQure NV would be worth today using our QURE stock calculator.
$703.00M
-
0.00%
14.46M
$14.16
$12.54
$13.01
$19.18
$3.73
Ready to start your investing journey with Stake?
Open an accountQURE FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in QURE
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in QURE
on Stake
Buy QURE from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of QURE from only US$10 with fractional shares
